TipHub

₹1,777.9

▼ -11.09 -0.62%

29 Jul 2026

NSE Listed · Pharmaceuticals

IPCA Laboratories Ltd. (IPCALAB)

Volume: 59,249Avg Vol 1W: 1,31,862Avg Vol 1M: 2,83,96052W Range:₹1,251.6₹1,944.9
NSE BSE www.ipca.com AI Report
Key Ratios
Checked just now
Market Cap₹45,106 Cr
Current Price₹1,777.9
Previous Close₹1,788.99
High / Low (52w)₹1,944.9 / ₹1,251.6
Volume59,249
Avg Vol (1W)1,31,862
Avg Vol (1M)2,83,960
Stock P/E133.58
Book Value₹317.85
Dividend Yield0.38%
ROE14.15%
ROA9.63%
Revenue (TTM)—
Revenue Growth16.02%
Profit Margin11.83%
Total Debt₹543 Cr
Shares Outstanding25 Cr
Face Value₹1
EPS (TTM)₹13.31
P/B5.59
Debt / Equity0.1
50 DMA₹1,679.09
200 DMA₹1,511.04
Day change-0.62%
Price Chart
₹1,777.9▲ 19.44% · 1Y
₹1901₹127141.3L
2025-07-29
2026-07-29

20-day avg volume: 2.6L shares

Pros
  • Company is almost debt-free.
Cons
  • Revenue fell 82% YoY.
  • Stock trades at a high P/E of 134.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹2,093 Cr₹2,355 Cr₹2,245 Cr₹2,247 Cr₹2,309 Cr₹2,557 Cr₹2,393 Cr₹2,388 Cr
EBITDA₹314 Cr₹367 Cr₹385 Cr₹355 Cr₹349 Cr₹469 Cr₹446 Cr₹470 Cr
Net Profit₹192 Cr₹229 Cr₹248 Cr₹68 Cr₹233 Cr₹283 Cr₹326 Cr₹299 Cr
EPS————————
Profit & Loss (Annual)
MetricDec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026
Revenue₹1,663 Cr₹1,638 Cr₹9,032 Cr₹1,747 Cr₹1,930 Cr₹1,845 Cr₹1,814 Cr₹9,821 Cr
EBITDA₹366 Cr₹315 Cr₹1,421 Cr₹369 Cr₹420 Cr₹427 Cr₹391 Cr₹1,735 Cr
Net Profit₹268 Cr₹-65 Cr₹738 Cr₹262 Cr₹305 Cr₹303 Cr₹262 Cr₹1,141 Cr
EPS——29.08————44.98
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹4,551 Cr₹5,260 Cr₹6,068 Cr₹7,639 Cr₹8,626 Cr₹11,101 Cr₹11,761 Cr₹12,370 Cr
Total Liabilities₹1,413 Cr₹1,619 Cr₹1,352 Cr₹2,070 Cr₹2,711 Cr₹3,374 Cr₹3,372 Cr₹2,846 Cr
Equity₹3,138 Cr₹3,641 Cr₹4,716 Cr₹5,569 Cr₹5,915 Cr₹7,727 Cr₹8,388 Cr₹9,524 Cr
Total Debt————————
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹612 Cr₹723 Cr₹1,336 Cr₹1,058 Cr₹1,029 Cr₹1,241 Cr₹1,683 Cr₹1,556 Cr
Investing₹-165 Cr₹-510 Cr₹-521 Cr₹-855 Cr₹-725 Cr₹-1,292 Cr₹-869 Cr₹-247 Cr
Financing₹-183 Cr₹-137 Cr₹-306 Cr₹427 Cr₹507 Cr₹-553 Cr₹-283 Cr₹-754 Cr
Free Cash Flow₹612 Cr₹723 Cr₹1,336 Cr₹1,058 Cr₹1,029 Cr₹1,241 Cr₹1,683 Cr₹1,556 Cr
Shareholding
Promoter 44.72% Institutions 48.1% Public 7.18%
Efficiency & Working Capital
ROCE18.6%
Interest Coverage20.9
Dividend Payout—
Debtor Days76 d
Inventory Days103 d
Payable Days36 d
Cash Conversion Cycle144 d
Working Capital Days180 d
Shareholding Details

As of 2026-06-30

Promoter44.7%
FII10.7%
DII37.4%
Institutions48.1%
Public7.2%
Promoter Pledge0%
No. of Shareholders82,060
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters46.3%46.3%46.3%46.3%46.3%44.7%44.7%44.7%44.7%44.7%44.7%44.7%
FIIs9.9%10.3%10.5%10.9%10.8%11.1%10.8%10.7%10.4%10.6%10.6%10.7%
DIIs35%33.8%34.4%33.8%34.2%35.7%36.1%36.2%36.8%37.3%37.4%37.4%
Public8.8%9.6%8.8%9.1%8.6%8.5%8.5%8.4%8.1%7.3%7.2%7.2%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders95,93082,80981,16584,75382,97590,18988,30685,58282,87077,67382,18482,060
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Kaygee Investments Private LimitedShareholding of Promoter and Promoter Group25.5%6.47 Cr
Hdfc Mutual FundPublic Shareholding9.5%2.42 Cr
Kaygee Laboratories Private LimitedShareholding of Promoter and Promoter Group6.6%1.68 Cr
Kotak Mahindra Mutual FundPublic Shareholding6.4%1.61 Cr
Chandurkar Investments Private LimitedShareholding of Promoter and Promoter Group5.5%1.40 Cr
Dsp Mutual FundPublic Shareholding4.6%1.18 Cr
Sbi Life Insurance Co. LtdPublic Shareholding3.7%93,72,522
Nippon India Mutual FundPublic Shareholding2.8%70,83,656
Premchand GodhaShareholding of Promoter and Promoter Group2.3%58,14,680
Axis Mutual FundPublic Shareholding1.9%49,11,931
Usha M ChandurkarShareholding of Promoter and Promoter Group1.7%43,02,000
Hdfc Life Insurance Company LimitedPublic Shareholding1.4%35,17,311
Edelweiss Trusteeship Company LtdPublic Shareholding1.2%30,19,905
Kotak Funds - India Midcap FundPublic Shareholding1.1%28,95,885
Hsbc Mutual FundPublic Shareholding1.1%26,76,396
Mfs International New Discovery FundPublic Shareholding1%26,22,997
Usha Premchand GodhaShareholding of Promoter and Promoter Group1%24,18,740
Sameer M ChandurkarShareholding of Promoter and Promoter Group0.8%20,00,000
Pranay GodhaShareholding of Promoter and Promoter Group0.7%17,00,990
Prashant GodhaShareholding of Promoter and Promoter Group0.6%15,68,644
Kalpana JainShareholding of Promoter and Promoter Group0.1%2,30,000
Xbees Traders LlpShareholding of Promoter and Promoter Group0%31,000
Makers Laboratories LimitedShareholding of Promoter and Promoter Group0%960
Bhawna GodhaShareholding of Promoter and Promoter Group0%5,000
Neetu GodhaShareholding of Promoter and Promoter Group0%4,000
Board of Directors
NameDesignationYear
Premchand GodhaExecutive Chairman2025
A K JainManaging Director & CFO2025
Pranay GodhaManaging Director & Chief Executive Officer2025
Prashant GodhaExecutive Director2025
Kamal Kishore SethIndependent Non Exe. Director2025
Narendra MairpadyIndependent Non Exe. Director2025
Harish P KamathCompany Sec. & Compli. Officer2025
Swati PatankarIndependent Director2025
Vivek ShiralkarIndependent Director2025
Segments — Product
SegmentRevenueShare
Pharmaceuticals₹0 Cr—
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹1582625
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-13Board Meetings—
forthcoming2026-08-07Dividend (6/- per share)Final
dividend2026-08-07₹6 (600%)Final
dividend2025-08-05₹2 (200%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2026590163666953940
2026010001
202630113712244477
Insider / Designated-Person Trades

5 recent disclosure(s)

MANISH KUMAR JAINDisposal · 3,000
Pawan KothariDisposal · 2,220
Mexin Medicaments Pvt. Ltd.Disposal · 14,058
Paschim Chemicals Pvt. Ltd.Disposal · 1,01,73,000
Kaygee Investments Pvt. Ltd.Acquisition · 1,01,87,058
Substantial Acquisitions (SAST)

3 disclosure(s)

Market18/12/2024 · 40,00,000
Market04/09/2024 · 51,23,142
Market02/08/2024 · 4,09,318
Company Information
Incorporated1949
ChairmanPremchand Godha
AuditorNVC & Associates LLP
Investor Email[email protected] ; [email protected]
🌐 www.ipca.com ↗

📍 48 Kandivli Industrial Estate, Kandivli (West), Mumbai, Maharashtra, 400067

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Invicta Diagnostic Ltd.Investment & Precision Castings Ltd.Indian Overseas BankIndian Oil Corporation Ltd.IOL Chemicals & Pharmaceuticals Ltd.Ion Exchange (India) Ltd.Indian Phosphate LimitedIndia Pesticides LimitedIntegrated Personnel Services Ltd.IRB Infrastructure Developers Ltd.IRB InvIT FundIrb Infrastructure TrustAll “I” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search